Chemoinformaics analysis of 9,12-octadecadienoic acid (Z,Z)-, methyl ester
Molecular Weight | 294.479 | nRot | 14 |
Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
Exact Molecular Weight | 294.256 | nRing | 0 |
Solubility: LogS | -3.643 | nHRing | 0 |
Solubility: LogP | 5.022 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 56.005 |
nHD | 0 | BPOL | 36.713 |
QED | 0.224 |
Synth | 2.313 |
Natural Product Likeliness | 1.03 |
NR-PPAR-gamma | 0.311 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.059 |
CACO-2 | -4.858 |
MDCK | 0.0000479 |
BBB | 0.908 |
PPB | 0.978753 |
VDSS | 2.86 |
FU | 0.016753 |
CYP1A2-inh | 0.648 |
CYP1A2-sub | 0.621 |
CYP2c19-inh | 0.518 |
CYP2c19-sub | 0.182 |
CYP2c9-inh | 0.423 |
CYP2c9-sub | 0.951 |
CYP2d6-inh | 0.603 |
CYP2d6-sub | 0.87 |
CYP3a4-inh | 0.803 |
CYP3a4-sub | 0.121 |
CL | 5.396 |
T12 | 0.913 |
hERG | 0.167 |
Ames | 0.225 |
ROA | 0.036 |
SkinSen | 0.961 |
Carcinogencity | 0.352 |
EI | 0.474 |
Respiratory | 0.775 |
NR-Aromatase | 0.081 |
Antiviral | No |
Prediction | 0.599226 |